• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估疾病与伤害预防项目的有效性:成本与后果。

Assessing the effectiveness of disease and injury prevention programs: costs and consequences.

出版信息

MMWR Recomm Rep. 1995 Aug 18;44(RR-10):1-10.

PMID:7565538
Abstract

Because resources are finite, public health decision makers need to consider the costs and effectiveness of alternative prevention strategies. A simplified approach to performing marginal cost-effectiveness analyses requires a) a description of the program, b) a description of the health outcomes averted and the timing of those events, c) the rates of the health outcome, d) the preventable fraction of the health outcomes averted, e) the costs per unit of the intervention, and f) the direct medical costs of the health outcome prevented and the side effects incurred. With this information, the marginal cost-effectiveness of an intervention can be determined and applied for decision making.

摘要

由于资源有限,公共卫生决策者需要考虑替代预防策略的成本和效果。进行边际成本效益分析的一种简化方法需要:a)对项目的描述;b)对避免的健康结果及其发生时间的描述;c)健康结果的发生率;d)避免的健康结果的可预防比例;e)每单位干预措施的成本;f)预防的健康结果的直接医疗成本和产生的副作用。有了这些信息,就可以确定一项干预措施的边际成本效益,并将其应用于决策。

相似文献

1
Assessing the effectiveness of disease and injury prevention programs: costs and consequences.评估疾病与伤害预防项目的有效性:成本与后果。
MMWR Recomm Rep. 1995 Aug 18;44(RR-10):1-10.
2
A framework for assessing the effectiveness of disease and injury prevention.一种评估疾病和伤害预防效果的框架。
MMWR Recomm Rep. 1992 Mar 27;41(RR-3):1-12.
3
Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?利用成本效益/成本效益分析来分配卫生资源:预防的公平竞争环境?
Am J Prev Med. 1997 Jan-Feb;13(1):18-25.
4
Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.预防性干预措施的剖析性成本效益分析:决策者指南
Am J Manag Care. 1999 Mar;5(3):301-5.
5
Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.开发和验证一个微观模拟经济模型,以评估与吸烟相关的疾病负担以及拉丁美洲烟草控制干预措施的成本效益。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S51-9. doi: 10.1016/j.jval.2011.05.010.
6
Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale?联邦政府资助的州组织癌症检测项目的平均成本差异:规模经济?
Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S67-79. doi: 10.1177/027298902237707.
7
Difficult decisions: weighing treatment costs and benefits.
Hosp Technol Ser. 1995 Jan;14(1):1-3.
8
Assessing outcomes in population health: moving the field forward.评估人群健康的结果:推动该领域向前发展。
Am J Prev Med. 1997 Jan-Feb;13(1):3-5.
9
HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.艾滋病病毒预防成本与项目规模:来自五个低收入和中等收入国家的PANCEA项目数据。
BMC Health Serv Res. 2007 Jul 12;7:108. doi: 10.1186/1472-6963-7-108.
10
Prevention research and its actual application to health services.预防研究及其在卫生服务中的实际应用。
J Behav Health Serv Res. 2001 May;28(2):118-29. doi: 10.1007/BF02287455.

引用本文的文献

1
Impact assessment of e-trainings in occupational safety and health: a literature review.电子培训在职业安全与健康方面的影响评估:文献综述。
BMC Public Health. 2023 Jun 20;23(1):1187. doi: 10.1186/s12889-023-16114-8.
2
An individually randomized controlled trial of a mother-daughter HIV/STI prevention program for adolescent girls and young women in South Africa: IMARA-SA study protocol.一项针对南非青少年女孩和年轻女性的母子 HIV/性传播感染预防计划的个体化随机对照试验:IMARA-SA 研究方案。
BMC Public Health. 2021 Sep 20;21(1):1708. doi: 10.1186/s12889-021-11727-3.
3
20 Years of Public Health Economics and Decision Sciences at the US Centers for Disease Control and Prevention: The CDC Steven M. Teutsch Prevention Effectiveness Fellowship, 1995-2015.
美国疾病控制与预防中心20年的公共卫生经济学与决策科学:1995 - 2015年美国疾病控制与预防中心史蒂文·M·特乌施预防效果奖学金项目
J Public Health Manag Pract. 2017 Jul/Aug;23(4):e14-e21. doi: 10.1097/PHH.0000000000000437.
4
Net financial benefits of averting HIV infections among people who inject drugs in Urumqi, Xinjiang, Peoples Republic of China (2005-2010).中国新疆乌鲁木齐市避免吸毒人群中 HIV 感染的净财务效益(2005-2010 年)。
BMC Public Health. 2012 Jul 29;12:572. doi: 10.1186/1471-2458-12-572.
5
Health promotion: causes, beliefs and measurements.健康促进:原因、观念与衡量方法。
Clin Med Res. 2003 Jul;1(3):249-58. doi: 10.3121/cmr.1.3.249.
6
Prevention for HIV-seropositive persons: successive approximation toward a new identity.针对HIV血清阳性者的预防:逐步接近新身份认同。
Behav Modif. 2005 Mar;29(2):227-55. doi: 10.1177/0145445504272599.
7
When there is too much to do: how practicing physicians prioritize among recommended interventions.当有太多事情要做时:执业医师如何在推荐的干预措施中进行优先级排序。
J Gen Intern Med. 2004 Jun;19(6):646-53. doi: 10.1007/s11606-004-0058-0.